Shang‐Gin Wu
0000-0001-8889-689X
Publication & Citation Trends
Most Cited Works
Publications
119 total
Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer PDF
Cited by 811
OpenAlex
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients PDF
Cited by 234
OpenAlex
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion–Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
Cited by 79
OpenAlex
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer PDF
Cited by 87
OpenAlex
Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations
Cited by 81
OpenAlex
Clinical Outcomes in Non–Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR PDF
Cited by 73
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(91)
Lung Cancer Diagnosis and Treatment
(49)
Lung Cancer Research Studies
(29)
Radiomics and Machine Learning in Medical Imaging
(22)
RNA modifications and cancer
(16)
Frequent Co-Authors
Affiliations
St. George's University
National Taiwan University
National Taiwan University Hospital
First People's Hospital of Chongqing
Taipei Medical University